NICHD Cooperative Multicenter Neonatal Research Network

NICHD 多中心新生儿合作研究网络

基本信息

  • 批准号:
    7103904
  • 负责人:
  • 金额:
    $ 60.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-05 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Division of Neonatology of the University of Iowa Carver College of Medicine submits this application to become a participating center in the NICHD Cooperative Multicenter Neonatal Research Network (RFAHD-04-010). Our NICU admits between 750 and 800 infants per year, including 350 to 500 inborn infants. The number of admissions has been increasing in the past 3 years, and in fiscal year 2004, we had 808 admissions, including 447 inborn infants. The University of Iowa, Division of Neonatology offers four special strengths to the Network. 1. Our clinical excellence with outcomes among the best in the world. Our standardized mortality ratio for very-low-birth-weight infants is perennially among the lowest (best) 15% in the Vermont Oxford Network. 2. Our strong tradition and track record of important contributions in clinical research in neonates and infants. We have a robust infrastructure for the conduct and support of clinical research and a strong track record of productivity. 3. Our capabilities in the area of genetics and our existing Iowa Perinatal Research DNA Bank. Founded in 1999, this bank contains nearly 3000 DNA samples and corresponding epidemiological data. These samples and data are being used in research examining the genetic factors that influence the occurrence and evolution of disease. Our DNA bank was one of the first examples of a comprehensive attempt to collect DNA from all infants born in a hospital. We believe this innovative resource has tremendous potential for unraveling the basis of many health problems faced in infancy, many with lifelong implications. 4. As the only academic medical center in a largely rural state with an economy based in agriculture, we represent a population that is currently not well represented in the NICHD Network. Moreover, lowans have an unusually sophisticated appreciation for the importance of maternal and child health, derived from their economic and personal interest in animal husbandry, lowans also have a sophisticated appreciation for the power and importance of genetics, derived from their agricultural interests. The applicant investigators and institution are firmly committed to the concept of multicenter clinical trials as the most powerful tool for evaluating new therapies, and we will fully subscribe to the Network's vision.
描述(由申请人提供):爱荷华大学卡弗医学院新生儿学部提交此申请,希望成为NICHD合作多中心新生儿研究网络(RFAHD-04-010)的参与中心。我们的新生儿重症监护室每年接收750至800名婴儿,其中包括350至500名新生儿。在过去的三年里,入学人数一直在增加,在2004财政年度,我们有808名入学人数,其中包括447名新生儿。爱荷华大学新生儿科为该网络提供了四个特殊优势。我们的临床效果在世界上名列前茅。我们非常低出生体重婴儿的标准化死亡率在佛蒙特牛津网络中一直处于最低(最好)的15%之列。我们在新生儿和婴儿临床研究方面的强大传统和重要贡献的记录。我们拥有开展和支持临床研究的强大基础设施以及良好的生产力记录。3. 我们在遗传学领域的能力和我们现有的爱荷华围产期研究DNA银行。该银行成立于1999年,拥有近3000份DNA样本和相应的流行病学数据。这些样本和数据正在用于研究影响疾病发生和演变的遗传因素。我们的DNA银行是第一个全面尝试从医院出生的所有婴儿收集DNA的例子之一。我们相信,这一创新资源具有巨大的潜力,可以解开婴儿时期面临的许多健康问题的基础,其中许多问题会影响一生。4. 作为一个主要以农业为经济基础的农村国家唯一的学术医疗中心,我们代表的人口目前在NICHD网络中没有得到很好的代表。此外,由于他们对畜牧业的经济和个人兴趣,lowans对孕产妇和儿童健康的重要性有着不同寻常的深刻认识,lowans也对遗传学的力量和重要性有着深刻的认识,这源于他们对农业的兴趣。申请研究人员和机构坚定地致力于将多中心临床试验作为评估新疗法最有力的工具的概念,我们将完全赞同网络的愿景。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD F BELL其他文献

EDWARD F BELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD F BELL', 18)}}的其他基金

Transfusion-Associated Brain Improvement (TABI) trial - CCC
输血相关大脑改善 (TABI) 试验 - CCC
  • 批准号:
    8269508
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
Transfusion-Associated Brain Improvement (TABI) trial - CCC
输血相关大脑改善 (TABI) 试验 - CCC
  • 批准号:
    8514715
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
Transfusion-Associated Brain Improvement (TABI) trial - CCC
输血相关大脑改善 (TABI) 试验 - CCC
  • 批准号:
    8849489
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
PROCALCITONIN, INTERLEUKIN-10, AND CD64 AS MARKERS OF NEONATAL SEPSIS
降钙素原、白细胞介素 10 和 CD64 作为新生儿败血症的标志物
  • 批准号:
    7604923
  • 财政年份:
    2007
  • 资助金额:
    $ 60.8万
  • 项目类别:
SURVEY OF OUTCOMES OF VERY LOW BIRTH WEIGHT INFANTS (401-1500 GRAMS) (GDB)
极低出生体重婴儿(401-1500 克)的结果调查 (GDB)
  • 批准号:
    7604913
  • 财政年份:
    2007
  • 资助金额:
    $ 60.8万
  • 项目类别:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL (SUPPORT)
表面活性剂气道正压和脉搏血氧饱和度试验(支持)
  • 批准号:
    7604915
  • 财政年份:
    2007
  • 资助金额:
    $ 60.8万
  • 项目类别:
HEAT LOSS PREVENTION IN THE DELIVERY ROOM
产房内的热损失预防
  • 批准号:
    7604838
  • 财政年份:
    2007
  • 资助金额:
    $ 60.8万
  • 项目类别:
EARLY DIAGNOSIS OF NOSOCOMIAL CANDIDIASIS
院内念珠菌病的早期诊断
  • 批准号:
    7604910
  • 财政年份:
    2007
  • 资助金额:
    $ 60.8万
  • 项目类别:
NICHD Cooperative Multicenter Neonatal Research Network
NICHD 多中心新生儿合作研究网络
  • 批准号:
    8081297
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:
NICHD Cooperative Multicenter Neonatal Research Network
NICHD 多中心新生儿合作研究网络
  • 批准号:
    8641710
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:

相似海外基金

From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
  • 批准号:
    MR/Y013050/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
  • 批准号:
    495575
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Operating Grants
Core B: Clinical Trials Core
核心 B:临床试验核心
  • 批准号:
    10554476
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
  • 批准号:
    2884930
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
  • 批准号:
    10855627
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
  • 批准号:
    10895949
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
  • 批准号:
    10891325
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
  • 批准号:
    10761602
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
  • 批准号:
    10758129
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了